HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: Implications for timing of therapy

ANTONIO RIVERO ROMÁNJULIAN CARLOS DE LA TORRE CISNEROS2026-01-292026-01-29201710.1038/tpj.2016.422-s2.0-84973154514https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27138GeneticsMolecular MedicinePharmacologyHLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: Implications for timing of therapyresearch article